Atrial Fibrillation Trial, Recruiting NCT06754176 Sponsor: University of California, San Francisco Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06754176
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are comfortable reading and writing in English
  • People who own a smartphone and are willing and able to use a specific mobile app called Eureka
  • People who have been diagnosed with a type of irregular heartbeat called paroxysmal atrial fibrillation (AFib), where episodes come and go, and who do not have plans to change how their AFib is being managed during the two-week study period
  • People who have had at least one AFib episode in the past month, or who a healthcare provider believes could potentially have an episode in the next month
  • People who have drunk alcohol on at least one day per week on average over the past month
  • People who are willing and able to be randomly assigned each day — either to avoid drinking alcohol or to not avoid it — over a two-week period
  • People who are willing and able to give written consent to participate

Who may not be able to join:

  • People whose only experience of AFib occurred after a surgical procedure
  • People whose heart has a very high rate of being paced by a device (more than 40% of the time) (confirm with trial site)
  • People with a history of alcohol addiction or alcohol misuse, as determined by self-reported history or a screening questionnaire
  • People who have an intolerance to alcohol
  • People with a history of liver disease
  • People who are currently incarcerated
  • People who are currently pregnant or trying to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gregory Marcus, MD, MAS, University of California, San Francisco

Phone: 415-476-5706

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 April 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Presence or Absence of Discrete Atrial Fibrillation Episodes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov